|
Injection Depot Medroxy Progesterene Acetate (DMPA):Our experience at tertiary care teaching hospital
|
Swati Gurav *1   , Uma Wankhede2 |
1- Assistant Professor , swati.gurav2009@gmail.com
2- Professor and head of Department |
|
|
Abstract: (1689 Views) |
ABSTRACT:-
Background: Injectable Contraceptive is fourth most popular family planning method worldwide after female sterilization, intra uterine contraceptive device & oral contraceptive. Postpartum contraception is crucial for health of women.
METHOD:-
This was retrospective study from 1st Jan 2020 to 28th Feb 2021 at tertiary care teaching hospital in pune Aim of study was to know demographic details of DMPA (Depot Metroxy Progesterone Acetate)
users, side effects & compliance of Inj DMPA. Medical record of 117 women who opted for Inj DMPA after counseling regarding contraceptive options was studied.
RESULTS:-
Most common side effect observed in Inj DMPA users was menstrual disorder irregular bleeding 62.3% followed by weight gain, amenorrhea & headache in 8.54%,3.41% & 1.7% women respectively. 29% women were para one while majority of DMPA users belonged to 21 to 25 years of age group.
CONCLUSION:-
MPA is highly effective, safe, long term reversible contraceptive option. Proper counseling if done before & after administration of Inj DMPA lead to better patient compliance.
Key words DMPA, postpartum contraception, family planning,
|
|
| Keywords: Key words DMPA, postpartum contraception, family planning |
|
|
Full-Text [DOC 223 kb]
(256 Downloads)
|
Type of Study: Original Article |
Subject:
Clinical Medicine
Received: 2023/06/16 | Accepted: 2024/06/11 | Published: 2024/06/11
|
|
|
|
|
|
